Resveratrol ameliorates experimental autoimmune myocarditis

Area of Science:

• Cardiology
• Immunology
• Pharmacology

Background:

• Autoimmune myocarditis in rats serves as a model for human dilated cardiomyopathy.
• Resveratrol, a polyphenol from grapes and wine, exhibits cardioprotective and immunomodulatory properties.

Purpose of the Study:

• To investigate the therapeutic effects of resveratrol on autoimmune myocarditis in a rat model.
• To assess resveratrol's impact on cardiac function, myocardial injury, and inflammatory markers.

Main Methods:

• Rats were immunized with cardiac myosin and treated with resveratrol (50 mg/kg/day) or vehicle.
• Cardiac function was evaluated using echocardiography.
• Myocardial histology, inflammatory cytokine expression, and antioxidant gene expression were analyzed.

Main Results:

• Resveratrol preserved cardiac function and attenuated cardiac hypertrophy in myosin-immunized rats.
• Resveratrol significantly reduced myocardial cellular infiltration, fibrosis, and inflammatory cytokine expression.
• Resveratrol modulated the expression of antioxidant genes and increased SIRT1 levels in the myocardium.

Conclusions:

• Resveratrol effectively ameliorated myocardial injury and preserved cardiac function in a rat model of autoimmune myocarditis.
• Resveratrol demonstrates potential as a therapeutic agent for myocarditis.